Adaptive Messaging for Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how text messaging can assist in managing depression. It tests two types of messaging: one adapts based on user feedback (Adaptive Messaging Intervention), while the other sends random messages (Non-Adaptive Messaging Intervention). Another group receives links to educational resources (Psychoeducation-Only Control). Individuals with moderate depression symptoms who own a smartphone may be suitable for this trial. The goal is to determine which method most effectively reduces symptoms and improves engagement. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance depression management for many.
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop your current medications, but you cannot join if you've changed your psychiatric medication dose in the past 4 weeks or plan to change it during the trial.
What prior data suggests that this adaptive messaging intervention is safe for managing depression?
Research has shown that text messaging programs for depression are generally safe. In studies of similar programs, participants received messages without major problems. For programs that adjust messages based on user feedback, one study found that over 99% of participants received the messages as planned, indicating the system works well and is well-liked.
Programs that send the same messages to everyone also appear safe. In one study, participants' depression symptoms improved, demonstrating the messages were helpful and did not cause harm. No major negative events were reported in these studies.
Overall, current research suggests that both types of messaging programs are safe. Participants did not report serious side effects, and the programs were generally well-received.12345Why are researchers excited about this trial?
Researchers are excited about these messaging interventions for depression because they leverage technology in a new way to enhance treatment engagement. Unlike traditional methods, such as medication and therapy, these interventions use daily SMS text messages to encourage the use of cognitive and behavioral strategies. The Adaptive Messaging Intervention is particularly groundbreaking because it utilizes reinforcement learning to tailor message styles to individual users, potentially increasing user engagement and effectiveness. This personalized approach could offer a more flexible and accessible option for managing depression, especially for individuals who might struggle with conventional therapy settings.
What evidence suggests that this trial's messaging interventions could be effective for depression?
This trial will compare different messaging interventions for depression. Research has shown that personalized messaging can assist people with depression. One study found that 42.4% of participants in a personalized messaging program experienced improved depression symptoms, compared to 32.2% in a standard program. In this trial, the Adaptive Messaging Intervention uses smart technology to customize messages, potentially increasing user engagement and effectiveness. The Non-Adaptive Messaging Intervention, which represents standard messaging, also demonstrated some improvement in mental health, but it may not be as effective as the personalized approach. Both methods can help reduce depression, but the personalized system might better engage users and improve outcomes.12367
Are You a Good Fit for This Trial?
This trial is for individuals experiencing elevated symptoms of depression. Participants will be recruited digitally and must be willing to engage with text messaging interventions over an 8-week period, followed by a 6-month post-treatment follow-up.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 8 weeks of daily text messaging interventions, either adaptive or non-adaptive, or a psychoeducation-only intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 3-month and 6-month intervals
What Are the Treatments Tested in This Trial?
Interventions
- Adaptive Messaging Intervention
- Non-Adaptive Messaging Intervention
- Psychoeducation-Only Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor